4.6 Editorial Material

Lung Injury in COVID-19-An Emerging Hypothesis

Journal

ACS CHEMICAL NEUROSCIENCE
Volume 11, Issue 15, Pages 2156-2158

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.0c00422

Keywords

COVID-19; Cytokine release syndrome; Interstitial pulmonary edema; Acute disseminated encephalomyelitis; Thromboembolic disease

Ask authors/readers for more resources

Lung injury with COVID-19 may be due to a complex underlying pathophysiology. Cytokine release syndrome appears to be a catalyst of different inflammatory pathways promoting lung parenchymal injury and thromboembolic phenomena (dual hit injury). Recently, severe neurological manifestations such as acute disseminated encephalomyelitis, which may be not linked to lung pathology, have been identified in COVID-19, contributing thus further to the versatility of its clinical features.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available